Activated Clotting Time and Haemostatic Complications in Patients Receiving ECMO Support: A Systematic Review
<b>Background</b>: Extracorporeal membrane oxygenation (ECMO) requires systemic anticoagulation to prevent clotting, typically using unfractionated heparin (UFH). However, anticoagulation carries a bleeding risk, necessitating monitoring. Activated clotting time (ACT) is a commonly used...
Saved in:
| Main Authors: | Daniel Schwaiger, Lukas Schausberger, Benedikt Treml, Dragana Jadzic, Nicole Innerhofer, Christoph Oberleitner, Zoran Bukumirić, Igor Spurnić, Sasa Rajsic |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-07-01
|
| Series: | Journal of Cardiovascular Development and Disease |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2308-3425/12/7/267 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Management of burn patients undergoing surgery while on extracorporeal membrane oxygenation (ECMO): clinical experience and a standardized perioperative protocol
by: Sonja Verena Schmidt, et al.
Published: (2025-08-01) -
PROTEOLYTIC ACTIVITY OF MILK-CLOTTING ENZYMES OF DIFFERENT ORIGIN
by: D. S. Myagkonosov, et al.
Published: (2022-03-01) -
Impact of different parameters on the outcome of vv-ECMO therapy in burn patients – a retrospective cohort study from a burn and high output ECMO center
by: Bingoel Alperen S., et al.
Published: (2024-09-01) -
The ProtekDuo Cannula for Venopulmonary ECMO as Bridge to Lung Transplantation: A Single Center Case Series
by: Yuriy Stukov, et al.
Published: (2025-04-01) -
Orthopaedic fracture surgery in polytraumatized patients while on extracorporeal membrane oxygenation (ECMO): A report of two cases
by: Jaquelyn Kakalecik, et al.
Published: (2024-06-01)